Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » FDA Approves AstraZeneca's Lynparza, Myriad Genetics' CDx for BRCA-Positive Pancreatic Cancer

FDA Approves AstraZeneca's Lynparza, Myriad Genetics' CDx for BRCA-Positive Pancreatic Cancer

Dec 30, 2019
|
staff reporter

NEW YORK – The US Food and Drug Administration expanded the indication for AstraZeneca and Merck's olaparib (Lynparza) as a maintenance treatment for certain metastatic pancreatic cancer patients identified with the help of a companion diagnostic, the two drugmakers announced on Monday.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Not Going With Verily

Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.

From Bread Bakery to Lab Space

The New York Times reports that developers in New York City are increasingly interested in life science spaces.

Decline in Antibodies

A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.

PNAS Papers on Diabetic Kidney Disease, Spontaneous Diploid Yeast Mutations, More

In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients

  2. FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies

  3. Helix Coronavirus Test FDA EUA Reissued to Include Specimen Self-Collection

  4. FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

  5. FDA Reissues EUA for Broad Institute Coronavirus Test, Authorizes Immunoassay From Celltrion

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.